Senzagen will be presenting a poster at the ASCCT meeting on Oct 20 from 4:45-6 pm EDT. Come join us to learn about how the GARDskin Dose-Response assay can be used for quantitative potency assessment!
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
Senzagen will be presenting a poster at the ASCCT meeting on Oct 20 from 4:45-6 pm EDT. Come join us to learn about how the GARDskin Dose-Response assay can be used for quantitative potency assessment! |
2 events,
-
In Vitro Skin Sensitization Testing with Human Relevance and High Accuracy In this webinar you will learn how combining genomics and machine learning provides a highly accurate in vitro method for assessment of skin sensitization hazard in medical device extracts, prepared according to ISO 10993-12. What You Will Learn Attendees will gain insights into: How GARD™skin Medical […] |
1 event, |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
1 event,
Wednesday, October 28, 2020 11:05 a.m. PT Joshua Schmidt, SenzaGen, Inc. "Leveraging in vitro to forecast in vivo success" |
0 events,
|
1 event,
New Approach Methodology Use for Regulatory Application (NURA) in collaboration with the Association for the Advancement of Alternatives Assessment (A4) is hosting two half day trainings to explore practical solutions for the safety assessment of cosmetics and consumer products. Lectures, discussions, and demonstrations will help attendees evaluate the advantages of new nonanimal approaches and apply them to […] |
0 events,
|
0 events,
|